4//SEC Filing
Symons Julian A. 4
Accession 0001567619-20-018006
CIK 0001799448other
Filed
Oct 19, 8:00 PM ET
Accepted
Oct 20, 4:57 PM ET
Size
13.9 KB
Accession
0001567619-20-018006
Insider Transaction Report
Form 4
Symons Julian A.
See Remarks
Transactions
- Conversion
Common Stock
2020-10-20+3,394→ 392,612 total - Conversion
Series B-2 Preferred Stock
2020-10-20−1,452→ 0 total→ Common Stock (1,452 underlying) - Conversion
Series A Preferred Stock
2020-10-20−13,671→ 0 total→ Common Stock (13,671 underlying) - Conversion
Common Stock
2020-10-20+13,671→ 389,218 total - Conversion
Common Stock
2020-10-20+1,452→ 394,064 total - Conversion
Series B-1 Preferred Stock
2020-10-20−3,394→ 0 total→ Common Stock (3,394 underlying)
Footnotes (1)
- [F1]Each share of the issuer's Series A Preferred Stock, Series B-1 Preferred Stock and Series B-2 Preferred Stock automatically converted into one (1) share of the issuer's Common Stock immediately upon the closing of the issuer's initial public offering on October 20, 2020 and had no expiration date.
Documents
Issuer
Aligos Therapeutics, Inc.
CIK 0001799448
Entity typeother
Related Parties
1- filerCIK 0001824727
Filing Metadata
- Form type
- 4
- Filed
- Oct 19, 8:00 PM ET
- Accepted
- Oct 20, 4:57 PM ET
- Size
- 13.9 KB